therapy, radiation therapy, erythropoietin anti-angiogenetic medicines (such as thalidomide and bevacizumab), hormonal therapy, platelet transfusion, and central venous catheter, are all treatment-related variables that significantly increase the risk of CT. 46 47 48 The risk of thrombosis is extremely significant during chemotherapy since patients might have many risk factors at the same time.
← all excerpts
The Saudi Consensus for the Management of Cancer-Associated Thromboembolism: A Modified Delphi-Based Study.
1
—
—